• Publications
  • Influence
Características clínicas y epidemiológicas de pacientes con espondiloatritis. Un estudio multicéntrico
Introduction: The term Spondylarthritis is a group of chronic inflammatory diseases, with similar clinical features of axial involvement, or peripheral arthritis, dactylitis, enthesitis, uveitis andExpand
Efecto de adición de un suplemento líquido portador de bacterias acidolácticas a dietas de alfalfa-concentrado y rastrojo de maíz-concentrado en ovinos
To determine the effects of a liquid supplement containing lactic acid bacteria(SULIBAL) on rumen fermentation and utilization of mixed diets of alfalfa or corn stover and commercial concentrates,Expand
AB0454 Biological therapies survival in adults and juvenile onset arthritis. data from biobadaguay registry
Background Survival of biological therapies (BT) may be considered as an indicator of efficacy and safety of the drug. BT survival have been studied mainly in adult’s patients, whereas only fewExpand
Safety and Survival Associated with Biologic Therapies: First Report of the Biobadaguay on the Paraguayan-Uruguayan Registry of Adverse Events with Biologic Therapies.
OBJECTIVE Analyze adverse events (AE) and survival associated with biologic therapies (BT) in the Biobadaguay, the Paraguayan Uruguayan registry of adverse events. METHODS Prospective,Expand
Caracterización clínicoepidemiológica de pacientes con enfermedades reumáticas de inicio juvenil en Paraguay (2011 – 2015)
Objective: Describe the frequency of juvenile onset rheumatologic inflammatory diseases (JIR ) in level III and IV complexity level hospitals in a quinquennium. Methods: Multicentric, descriptiveExpand
Safety and Survival Associated with Biologic Therapies: First Report of the Biobadaguay on the Paraguayan-Uruguayan Registry of Adverse Events with Biologic Therapies.
Abstract Objective Analyze adverse events (AE) and survival associated with biologic therapies (BT) in the BIOBADAGUAY, the Paraguayan Uruguayan registry of adverse events. Methods Prospective,Expand
AB0452 Biological therapy adverse events in biobadaguay registry
Background BIOBADAGUAY is the Paraguayan/Uruguayan registry of adverse events (AE) in patients with inflammatory rheumatic conditions under biologic therapy (BT) Objectives To determine the frequencyExpand
SAT0155 Traditional and nontraditional cardiovascular risk factors in patients with early onset arthritis of the panlar-eoa
Background: Inflammation plays a significant role in atherosclerosis and cardiovascular disease (CVD). Patients with chronic inflammatory diseases are at increased risk of CVD, but it is debatedExpand
AB0453 Biological therapies retention rate in two sudamerican countries. data from biobadaguay registry
Background The retention rates (RR) of biological therapies (BT) have been extensively studied in European countries and the United States, but there is a lack of information about them in emergingExpand